vs
Apple Hospitality REIT, Inc.（APLE）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
Apple Hospitality REIT, Inc.的季度营收约是IONIS PHARMACEUTICALS INC的1.7倍（$337.7M vs $203.3M），Apple Hospitality REIT, Inc.净利率更高（8.2% vs -112.8%，领先121.0%），Apple Hospitality REIT, Inc.同比增速更快（3.1% vs -10.3%），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs -6.9%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
APLE vs IONS — 直观对比
营收规模更大
APLE
是对方的1.7倍
$203.3M
营收增速更快
APLE
高出13.3%
-10.3%
净利率更高
APLE
高出121.0%
-112.8%
两年增速更快
IONS
近两年复合增速
-6.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $337.7M | $203.3M |
| 净利润 | $27.7M | $-229.4M |
| 毛利率 | — | 96.1% |
| 营业利润率 | 14.2% | -105.5% |
| 净利率 | 8.2% | -112.8% |
| 营收同比 | 3.1% | -10.3% |
| 净利润同比 | 12.7% | -119.8% |
| 每股收益（稀释后） | $0.12 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLEIONS
| Q1 26 | $337.7M | — | ||
| Q4 25 | $326.4M | $203.3M | ||
| Q3 25 | $373.9M | $156.7M | ||
| Q2 25 | $384.4M | $452.0M | ||
| Q1 25 | $327.7M | $131.6M | ||
| Q4 24 | $333.0M | $226.6M | ||
| Q3 24 | $378.8M | $133.8M | ||
| Q2 24 | $390.1M | $225.3M |
净利润APLEIONS
| Q1 26 | $27.7M | — | ||
| Q4 25 | $29.6M | $-229.4M | ||
| Q3 25 | $50.9M | $-128.6M | ||
| Q2 25 | $63.6M | $123.6M | ||
| Q1 25 | $31.2M | $-146.9M | ||
| Q4 24 | $29.8M | $-104.3M | ||
| Q3 24 | $56.3M | $-140.5M | ||
| Q2 24 | $73.9M | $-66.3M |
毛利率APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | 37.2% | 96.1% | ||
| Q3 25 | 40.6% | 98.5% | ||
| Q2 25 | 42.6% | 99.1% | ||
| Q1 25 | 39.0% | 98.9% | ||
| Q4 24 | 38.6% | 98.3% | ||
| Q3 24 | 41.9% | 99.2% | ||
| Q2 24 | 44.6% | 98.2% |
营业利润率APLEIONS
| Q1 26 | 14.2% | — | ||
| Q4 25 | 15.2% | -105.5% | ||
| Q3 25 | 19.4% | -102.2% | ||
| Q2 25 | 22.1% | 30.9% | ||
| Q1 25 | 15.5% | -111.6% | ||
| Q4 24 | 15.0% | -48.9% | ||
| Q3 24 | 20.5% | -111.1% | ||
| Q2 24 | 24.0% | -29.3% |
净利率APLEIONS
| Q1 26 | 8.2% | — | ||
| Q4 25 | 9.1% | -112.8% | ||
| Q3 25 | 13.6% | -82.1% | ||
| Q2 25 | 16.6% | 27.3% | ||
| Q1 25 | 9.5% | -111.6% | ||
| Q4 24 | 9.0% | -46.1% | ||
| Q3 24 | 14.9% | -105.0% | ||
| Q2 24 | 19.0% | -29.4% |
每股收益（稀释后）APLEIONS
| Q1 26 | $0.12 | — | ||
| Q4 25 | $0.13 | $-1.35 | ||
| Q3 25 | $0.21 | $-0.80 | ||
| Q2 25 | $0.27 | $0.70 | ||
| Q1 25 | $0.13 | $-0.93 | ||
| Q4 24 | $0.13 | $-0.66 | ||
| Q3 24 | $0.23 | $-0.95 | ||
| Q2 24 | $0.31 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.8M | $2.7B |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $3.1B | $489.1M |
| 总资产 | $4.9B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资APLEIONS
| Q1 26 | $7.8M | — | ||
| Q4 25 | $8.5M | $2.7B | ||
| Q3 25 | $50.3M | $2.2B | ||
| Q2 25 | $7.9M | $2.3B | ||
| Q1 25 | $14.9M | $2.1B | ||
| Q4 24 | $10.3M | $2.3B | ||
| Q3 24 | $6.1M | $2.5B | ||
| Q2 24 | $7.2M | $2.1B |
总债务APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $1.8B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — |
股东权益APLEIONS
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.1B | $489.1M | ||
| Q3 25 | $3.2B | $618.0M | ||
| Q2 25 | $3.2B | $631.7M | ||
| Q1 25 | $3.2B | $475.7M | ||
| Q4 24 | $3.3B | $588.4M | ||
| Q3 24 | $3.3B | $662.5M | ||
| Q2 24 | $3.3B | $263.7M |
总资产APLEIONS
| Q1 26 | $4.9B | — | ||
| Q4 25 | $4.9B | $3.5B | ||
| Q3 25 | $4.9B | $3.0B | ||
| Q2 25 | $4.9B | $3.0B | ||
| Q1 25 | $4.9B | $2.8B | ||
| Q4 24 | $5.0B | $3.0B | ||
| Q3 24 | $5.0B | $3.1B | ||
| Q2 24 | $5.1B | $2.7B |
负债/权益比APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | 0.49× | 3.71× | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.45× | 2.13× | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-159.0M |
| 自由现金流率自由现金流/营收 | — | -78.2% |
| 资本支出强度资本支出/营收 | — | 10.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-320.0M |
8季度趋势，按日历期对齐
经营现金流APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | $370.2M | $-137.7M | ||
| Q3 25 | $126.4M | $-131.4M | ||
| Q2 25 | $108.8M | $151.3M | ||
| Q1 25 | $49.1M | $-150.8M | ||
| Q4 24 | $405.4M | $-116.1M | ||
| Q3 24 | $128.2M | $-115.0M | ||
| Q2 24 | $127.3M | $-119.9M |
自由现金流APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | $282.0M | $-159.0M | ||
| Q3 25 | $109.0M | $-136.7M | ||
| Q2 25 | $96.2M | $139.0M | ||
| Q1 25 | $29.5M | $-163.4M | ||
| Q4 24 | $327.1M | $-141.6M | ||
| Q3 24 | $113.1M | $-124.0M | ||
| Q2 24 | $115.0M | $-126.1M |
自由现金流率APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | 86.4% | -78.2% | ||
| Q3 25 | 29.2% | -87.2% | ||
| Q2 25 | 25.0% | 30.8% | ||
| Q1 25 | 9.0% | -124.1% | ||
| Q4 24 | 98.2% | -62.5% | ||
| Q3 24 | 29.9% | -92.7% | ||
| Q2 24 | 29.5% | -56.0% |
资本支出强度APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | 27.0% | 10.5% | ||
| Q3 25 | 4.7% | 3.4% | ||
| Q2 25 | 3.3% | 2.7% | ||
| Q1 25 | 6.0% | 9.6% | ||
| Q4 24 | 23.5% | 11.3% | ||
| Q3 24 | 4.0% | 6.8% | ||
| Q2 24 | 3.2% | 2.8% |
现金转化率APLEIONS
| Q1 26 | — | — | ||
| Q4 25 | 12.50× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 1.71× | 1.22× | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 13.59× | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | 1.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Comparable Hotels Total Revenue | $336.9M | 100% |
| RevPAR (Comparable Hotels) | $114.6K | 0% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
